Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report

Although small cell neuroendocrine carcinoma of the ureter (ureteral SCNEC) is rare, it always leads to a poor prognosis. Also, no treatment recommendation has been given for ureteral SCNEC, with only PD-1/PD-L1 inhibitors being used for its treatment. Here, we report a case of atypical symptoms of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoying, Wen, Jing, Li, Hongtao, Huang, Yan, Zhou, Hongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073532/
https://www.ncbi.nlm.nih.gov/pubmed/37035192
http://dx.doi.org/10.3389/fonc.2023.1114397
_version_ 1785019586873131008
author Li, Xiaoying
Wen, Jing
Li, Hongtao
Huang, Yan
Zhou, Hongliang
author_facet Li, Xiaoying
Wen, Jing
Li, Hongtao
Huang, Yan
Zhou, Hongliang
author_sort Li, Xiaoying
collection PubMed
description Although small cell neuroendocrine carcinoma of the ureter (ureteral SCNEC) is rare, it always leads to a poor prognosis. Also, no treatment recommendation has been given for ureteral SCNEC, with only PD-1/PD-L1 inhibitors being used for its treatment. Here, we report a case of atypical symptoms of cardiac infarction caused by a PD-1 inhibitor used in the treatment of ureteral SCNEC and hope to address concerns regarding the possible cardiac toxicity caused by PD-1/PD-L1 inhibitors in ureteral SCNEC patients.
format Online
Article
Text
id pubmed-10073532
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100735322023-04-06 Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report Li, Xiaoying Wen, Jing Li, Hongtao Huang, Yan Zhou, Hongliang Front Oncol Oncology Although small cell neuroendocrine carcinoma of the ureter (ureteral SCNEC) is rare, it always leads to a poor prognosis. Also, no treatment recommendation has been given for ureteral SCNEC, with only PD-1/PD-L1 inhibitors being used for its treatment. Here, we report a case of atypical symptoms of cardiac infarction caused by a PD-1 inhibitor used in the treatment of ureteral SCNEC and hope to address concerns regarding the possible cardiac toxicity caused by PD-1/PD-L1 inhibitors in ureteral SCNEC patients. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10073532/ /pubmed/37035192 http://dx.doi.org/10.3389/fonc.2023.1114397 Text en Copyright © 2023 Li, Wen, Li, Huang and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Xiaoying
Wen, Jing
Li, Hongtao
Huang, Yan
Zhou, Hongliang
Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
title Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
title_full Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
title_fullStr Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
title_full_unstemmed Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
title_short Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
title_sort cardiac infarction caused by pd-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: a case report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073532/
https://www.ncbi.nlm.nih.gov/pubmed/37035192
http://dx.doi.org/10.3389/fonc.2023.1114397
work_keys_str_mv AT lixiaoying cardiacinfarctioncausedbypd1inhibitorduringsmallcellneuroendocrinecarcinomaoftheuretertreatmentacasereport
AT wenjing cardiacinfarctioncausedbypd1inhibitorduringsmallcellneuroendocrinecarcinomaoftheuretertreatmentacasereport
AT lihongtao cardiacinfarctioncausedbypd1inhibitorduringsmallcellneuroendocrinecarcinomaoftheuretertreatmentacasereport
AT huangyan cardiacinfarctioncausedbypd1inhibitorduringsmallcellneuroendocrinecarcinomaoftheuretertreatmentacasereport
AT zhouhongliang cardiacinfarctioncausedbypd1inhibitorduringsmallcellneuroendocrinecarcinomaoftheuretertreatmentacasereport

Ejemplares similares